% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • robert.scozzafava robert.scozzafava May 13, 2013 8:07 PM Flag

    2 good up i am shocked....I am only 50% down now.....

    what's with all the wall street analysts who were saying $30 - $35 a share? were they smoking too much dope?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Shhhhhh.... don't tell anybody, but I'm in @ $12.24.........BWAHAHAHAHAHAHAHAHAHA!!!! HEHEHEHE!!! lol

    • Geeze!! I thought I was the big loser at 40% down. I guess we have to hang in there for another year or so.

      Sentiment: Hold

    • Absolutely, agree with you. Nothing wrong with company, it's management and the product (Vascepa) itself. I believe, Management is doing a decent job so far. Disclosure, I am long this stock and still believe this company will be acquired sooner or later. But these analysts, I think jumped guns and made such bad calls last year. I would say, only Akiva Felt (Wedbush) made a reasonable call,at the right time. All the other analysts (price targets , Ritu Baral - $28, Aegis Capital - $35, JPM $19, Citi - $21, Leerink Swann -$26, MKM Partners $22 and a bunch of other analysts had price targets above $20). Lesson learned the hard way - When every analyst on WallStreet is bullish a certain stock, you absolutely gotta stay away from that stock. I have seen this time and again. I don't believe there was one analyst who was bearish AMRN around June-October 2012.
      It was a high risk/reward investment at that time. If Vascepa had received NCE decision last year (before November) , we probably would not be talking about this now. It just a bad luck for AMRN investors who were hoping for a quick buyout.

      Sentiment: Strong Buy

3.13-0.11(-3.40%)Sep 29 4:00 PMEDT